Trials in progress: Phase IB/II of CPX-351 as maintenance therapy in AML patients ineligible for bone marrow transplantation
Year: 2025
Type: conference-abstract
Source: Blood
Authors: Catherine Lai, Kimberley Doucette, Susan Mckay, Ashlena Livingston, Jed Osei, Ella Rutanen, Jacqueline Galdos, Kristina Krstanoska, Nicole Swanson, Kerrie Bouker, James McCloskey
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4417014098
Cites:
Cited by:
Related to: